Zoetis

Zoetis is the global leader in animal health, developing and manufacturing vaccines and medicines for both livestock and companion animals. As global populations rise and the humanisation of pets accelerates, Zoetis is ideally positioned to benefit from two structural growth drivers: Pet Humanisation and the Emerging Middle Class. Pet ownership is soaring across the developed and developing world, with spending on pet healthcare increasing significantly as pets are viewed as family members. Meanwhile, rising incomes and protein consumption in emerging markets are lifting demand for livestock productivity and health management. Zoetis’ diversified portfolio, innovation pipeline, and strong distribution network give it defensible advantages and pricing power. Its consistent investments in R&D and diagnostics, combined with its data-driven digital tools for vets and farmers, enhance its value proposition. Zoetis captures both ends of the animal care spectrum – from growing urban pet needs to efficient global food production.